Cited by 293Barrier Structure and Function StudiesAlzheimer's disease research and treatmentsIntracerebral and Subarachnoid Hemorrhage Research

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy

Carrano, Anna, Hoozemans, Jeroen J.M., van der Vies, Saskia M., Rozemuller, Annemieke J.M., van Horssen, Jack, de Vries, Helga E.·2011·Antioxidants & Redox Signaling

DOI 10.1089/ars.2011.3895

Open this paper in CoChat — free account

Abstract

Cerebral amyloid angiopathy (CAA) is frequently observed in Alzheimer's disease (AD) and is characterized by deposition of amyloid beta (Aβ) in leptomeningeal and cortical brain vasculature. In 40% of AD cases, Aβ mainly accumulates in cortical capillaries, a phenomenon referred to as capillary CAA (capCAA). The aim of this study was to investigate blood-brain barrier (BBB) alterations in CAA-affected capillaries with the emphasis on tight junction (TJ) changes. First, capCAA brain tissue was analyzed for the distribution of TJs. Here, we show for the first time a dramatic loss of occludin, claudin-5, and ZO-1 in Aβ-laden capillaries surrounded by NADPH oxidase-2 (NOX-2)-positive activated microglia. Importantly, we observed abundant vascular expression of the Aβ transporter receptor for advanced glycation endproducts (RAGE). To unravel the underlying mechanism, a human brain endothelial cell line was stimulated with Aβ1-42 to analyze the effects of Aβ. We observed a dose-dependent cytotoxicity and increased ROS generation, which interestingly was reversed by administration of exogenous antioxidants, NOX-2 inhibitors, and by blocking RAGE. Taken together, our data evidently show that Aβ is toxic to brain endothelial cells via binding to RAGE and induction of ROS production, which ultimately leads to disruption of TJs and loss of BBB integrity.

Integrity signals

Registry

Crossref · 10.1089/ars.2011.3895

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“Staging of AD was evaluated according to Braak and colleagues (7).”
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line
Weksler, B. B., Subileau, E.-A., Perrière, N., Charneau, P., Holloway, K. E., Leveque, M., Tricoire-Leignel, H., Nicotra, A., Bourdoulous, S., Turowski, P., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3458fje · Cited by 1,325
Cerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
Wautier, M., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e685 · Cited by 1,088
An Assessment of Oxidative Damage to Proteins, Lipids, and DNA in Brain from Patients with Alzheimer's Disease
Lyras, L., Cairns, N. J., Jenner, A., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052061.x · Cited by 531
RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease
Donahue, J. E., Flaherty, S. L., Johanson, C. E., Duncan, J. A., Silverberg, G. D., Miller, M. C., Tavares, R., Yang, W., Wu, Q., Sabo, E., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0115-3 · Cited by 519
Microvascular injury and blood–brain barrier leakage in Alzheimer's disease
Zipser, B. D., Johanson, C. E., Gonzalez, L., Berzin, T. M., Tavares, R., Hulette, C. M., Vitek, M. P., Hovanesian, V., & Stopa, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.016 · Cited by 487

Flagged first, then by citations

Show all 50 references

Research works printed but not linked: 5

10.1080/15216540051080976 · DOI
Higuchi Y, 1987, Jpn J Psychiatry Neurol, 41, 283
Kalaria RN, 1992, Cerebrovasc Brain Metab Rev, 4, 226
Tai LM, 2010, J Cell Mol Med, 14, 1101
Yamashita K, 1991, Jpn J Psychiatry Neurol, 45, 79

Sorted by citations

ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease
Simpson, D. S. A., & Oliver, P. L. (2020) · Antioxidants · doi:10.3390/antiox9080743 · Cited by 1,044
The blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583
Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease
Erickson, M. A., & Banks, W. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.135 · Cited by 572
Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review
Hopperton, K. E., Mohammad, D., Trépanier, M. O., Giuliano, V, & Bazinet, R. P. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.246 · Cited by 567
Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease
Yamazaki, Y., & Kanekiyo, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091965 · Cited by 451
Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders
Lochhead, J. J., Yang, J., Ronaldson, P. T., & Davis, T. P. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00914 · Cited by 445
NADPH oxidase in brain injury and neurodegenerative disorders
Ma, M. W., Wang, J., Zhang, Q., Wang, R., Dhandapani, K. M., Vadlamudi, R. K., & Brann, D. W. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0150-7 · Cited by 432
Factors controlling permeability of the blood–brain barrier
Almutairi, M. M., Chen, G., Xu, Y. G., Chang, Y., & Shi, H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2050-8 · Cited by 321
Cerebrovascular disease in ageing and Alzheimer’s disease
Love, S., & Miners, J. S. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1522-0 · Cited by 299
Factors influencing the blood-brain barrier permeability
Zhao, Y., Gan, L., Ren, L., Lin, Y., Ma, C., & Lin, X. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147937 · Cited by 291
Cerebrovascular and blood–brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology
Drouin‐Ouellet, J., Sawiak, S. J., Cisbani, G., Lagacé, M., Kuan, W., Saint‐Pierre, M., Dury, R. J., Alata, W., St‐Amour, I., Mason, S. L., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24406 · Cited by 288
Oxidative stress and β-amyloid protein in Alzheimer’s disease
Cai, Z., Zhao, B., & Ratka, A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8155-9 · Cited by 279
New Insights on NOX Enzymes in the Central Nervous System
Nayernia, Z., Jaquet, V., & Krause, K.-H. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5703 · Cited by 279
Blood–Brain Barrier Dysfunction in a 3D In Vitro Model of Alzheimer's Disease
Shin, Y., Choi, S. H., Kim, E., Bylykbashi, E., Kim, J. A., Chung, S. H., Kim, D. Y., Kamm, R. D., & Tanzi, R. E. (2019) · Advanced Science · doi:10.1002/advs.201900962 · Cited by 275
Blood–Brain Barrier Breakdown: An Emerging Biomarker of Cognitive Impairment in Normal Aging and Dementia
Hussain, B., Fang, C., & Chang, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.688090 · Cited by 255
Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders
Qosa, H., Miller, D. S., Pasinelli, P., & Trotti, D. (2015) · Brain Research · doi:10.1016/j.brainres.2015.07.005 · Cited by 249
Amyloid-β Contributes to Blood–Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy
Hartz, A. M. S., Bauer, B., Soldner, E. L. B., Wolf, A., Boy, S., Backhaus, R., Mihaljevic, I., Bogdahn, U., Klünemann, H. H., Schuierer, G., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.627562 · Cited by 248
Pathophysiology of RAGE in inflammatory diseases
Dong, H., Zhang, Y., Huang, Y., & Deng, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.931473 · Cited by 268
Oxidative Stress and Blood–Brain Barrier Dysfunction Under Particular Consideration of Matrix Metalloproteinases
Lehner, C., Gehwolf, R., Tempfer, H., Krizbai, I. A., Hennig, B., Bauer, H., & Bauer, H. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3923 · Cited by 236
The blood–brain barrier
Obermeier, B., Verma, A., & Ransohoff, R. M. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63432-0.00003-7 · Cited by 216
Selective loss of cortical endothelial tight junction proteins during Alzheimer’s disease progression
Yamazaki, Y., Shinohara, M., Shinohara, M., Yamazaki, A., Murray, M. E., Liesinger, A. M., Heckman, M. G., Lesser, E. R., Parisi, J. E., Petersen, R. C., et al. (2019) · Brain · doi:10.1093/brain/awz011 · Cited by 202
The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts
Arvanitakis, Z., Capuano, A. W., Leurgans, S. E., Buchman, A. S., Bennett, D. A. A., & Schneider, J. A. (2016) · Brain Pathology · doi:10.1111/bpa.12365 · Cited by 198
Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy
Blair, L. J., Frauen, H. D., Zhang, B., Nordhues, B. A., Bijan, S., Lin, Y.-C., Zamudio, F., Hernandez, L. D., Sabbagh, J. J., Selenica, M.-L. B., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0186-2 · Cited by 193
Mechanisms of Blood Brain Barrier Disruption by Different Types of Bacteria, and Bacterial–Host Interactions Facilitate the Bacterial Pathogen Invading the Brain
Al‐Obaidi, M. M. J., & Desa, M. N. M. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0609-2 · Cited by 195
Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy
Carrano, A., Hoozemans, J. J. M., van der Vies, S. M., van Horssen, J., de Vries, H. E., & Rozemuller, A. J. M. (2012) · Neurodegenerative Diseases · doi:10.1159/000334916 · Cited by 186
Self-citation
NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors
Cipriano, A., Viviano, M., Feoli, A., Milite, C., Sarno, G., Castellano, S., & Sbardella, G. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00770 · Cited by 208
Vascular cognitive impairment and dementia
Gorelick, P. B., Counts, S., & Nyenhuis, D. L. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.015 · Cited by 195
Dysfunction of the blood–brain barrier in Alzheimer's disease: Evidence from human studies
Kurz, C., Walker, L., Rauchmann, B., & Perneczky, R. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12782 · Cited by 183
“damage and CAA type 1 (capillary type), but not CAA type 2 (noncapillary type).(33,38,53,56) BBB damage (measured by fibrinogen extravasation) correlated with SVD and CAA pathology, and to a lesser degree with cortical AD-related pathology.”
Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases
Brkić, M., Balusu, S., Wonterghem, E. V., Gorlé, N., Benilova, I., Kremer, A., Hove, I. V., Moons, L., Strooper, B. D., Kanazir, S., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0006-15.2015 · Cited by 191
Oxidative Stress: A Major Player in Cerebrovascular Alterations Associated to Neurodegenerative Events
Carvalho, C., & Moreira, P. I. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00806 · Cited by 184
Vascular contributions to Alzheimer's disease
Eisenmenger, L. B., Peret, A., Famakin, B. M., Spahic, A., Roberts, G. S., Bockholt, J. H., Johnson, K. M., & Paulsen, J. S. (2022) · Translational research · doi:10.1016/j.trsl.2022.12.003 · Cited by 183
Blood-Brain Barrier Dysfunction in Normal Aging and Neurodegeneration: Mechanisms, Impact, and Treatments
Andjelkovic, A. V., Situ, M., Citalán‐Madrid, A. F., Stamatovic, S. M., Xiang, J., & Keep, R. F. (2023) · Stroke · doi:10.1161/strokeaha.122.040578 · Cited by 190
Oxidative stress and cerebral endothelial cells: Regulation of the blood–brain-barrier and antioxidant based interventions
Freeman, L. R., & Keller, J. N. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.009 · Cited by 181
Aβ1–42oligomer‐induced leakage in anin vitroblood–brain barrier model is associated with up‐regulation of RAGE and metalloproteinases, and down‐regulation of tight junction scaffold proteins
Wan, W., Cao, L., Liu, L., Zhang, C., Kalionis, B., Tai, X., Li, Y., & Xia, S. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13122 · Cited by 169
Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology
Nedić, O., Rattan, S. I. S., Grune, T., & Trougakos, I. P. (2013) · Free Radical Research · doi:10.3109/10715762.2013.806798 · Cited by 162
Autoregulated paracellular clearance of amyloid-β across the blood-brain barrier
Keaney, J., Walsh, D. M., O’Malley, T. T., Hudson, N., Crosbie, D. E., Loftus, T., Sheehan, F., McDaid, J., Humphries, M. M., Callanan, J. J., et al. (2015) · Science Advances · doi:10.1126/sciadv.1500472 · Cited by 152
Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer’s disease
Dorr, A. E., Sahota, B., Chinta, L. V., Brown, M. E., Lai, A. Y., Ma, K., Hawkes, C. A., McLaurin, J., & Stefanovic, B. (2012) · Brain · doi:10.1093/brain/aws243 · Cited by 156
Triggers and Effectors of Oxidative Stress at Blood-Brain Barrier Level: Relevance for Brain Ageing and Neurodegeneration
Enciu, A., Gherghiceanu, M., & Popescu, B. O. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/297512 · Cited by 157
Occludin Protein Family: Oxidative Stress and Reducing Conditions
Blasig, I. E., Bellmann, C., Cording, J., Vecchio, G. D., Zwanziger, D., Huber, O., & Haseloff, R. F. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3542 · Cited by 142
In Situ implantable, post-trauma microenvironment-responsive, ROS Depletion Hydrogels for the treatment of Traumatic brain injury
Qian, F., Han, Y., Han, Z., Zhang, D., Zhang, L., Zhao, G., Li, S., Jin, G., Yu, R., & Liu, H. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120675 · Cited by 137
Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics
Pan, Y., & Nicolazzo, J. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.009 · Cited by 131
Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
Burstein, A. H., Grimes, I., Galasko, D. R., Aisen, P. S. S., Sabbagh, M. N., & Mjalli, A. M. M. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-12 · Cited by 137
Pathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives
Fisher, R. A., Miners, J. S., & Love, S. (2022) · Brain Pathology · doi:10.1111/bpa.13061 · Cited by 133
Wumei Wan attenuates angiogenesis and inflammation by modulating RAGE signaling pathway in IBD: Network pharmacology analysis and experimental evidence
Duan, Z., Wang, Y., Lü, Z., Tian, L., Xia, Z.-Q., Wang, K., Chen, T., Wang, R., Feng, Z.-Y., Shi, G., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154658 · Cited by 131
Innate immunity receptor CD36 promotes cerebral amyloid angiopathy
Park, L., Zhou, J., Zhou, P., Pistick, R., Jamal, S. E., Younkin, L. H., Pierce, J. P., Arreguin, A. J., Anrather, J., Younkin, S. G., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300021110 · Cited by 132
Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus
Zhang, J., Zhen, Y., Pu-Bu-Ci-Ren, Song, L.-G., Kong, W.-N., Shao, T.-M., Li, X., & Xi-qing, C. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.037 · Cited by 131
Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance
Nehra, G., Bauer, B., & Hartz, A. M. S. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108119 · Cited by 127
High-dose of vitamin C supplementation reduces amyloid plaque burden and ameliorates pathological changes in the brain of 5XFAD mice
Kook, S.-Y., Lee, K.-M., Kim, Y., Cha, M.-Y., Kang, S., Baik, S., Lee, H., Park, R., & Mook‐Jung, I. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.26 · Cited by 129
Astragaloside IV protects blood-brain barrier integrity from LPS-induced disruption via activating Nrf2 antioxidant signaling pathway in mice
Li, H., Wang, P., Huang, F., Jin, J., Wu, H., Zhang, B., Wang, Z., Shi, H., & Wu, X. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.12.019 · Cited by 125
Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier
van Doorn, R., Pinheiro, M. A. L., Kooij, G., Lakeman, K. A. M., Hof, B. V. H., van der Pol, S. M. A., Geerts, D., van Horssen, J., van der Valk, P., van der Kam, E. L., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-133 · Cited by 124
Claudins: Control of Barrier Function and Regulation in Response to Oxidant Stress
Overgaard, C. E., Daugherty, B. L., Mitchell, L. A., & Koval, M. H. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3893 · Cited by 133
Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model
Jin, W., Shen, L., Bu, X., Zhang, W., Chen, S., Huang, Z., Xiong, J., Gao, C., Dong, Z., He, Y., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1721-y · Cited by 121
The blood brain barrier in Alzheimer’s disease
Chakraborty, A., de Wit, N. M., van der Flier, W. M., & de Vries, H. E. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2016.11.008 · Cited by 118
Insights into T‐cell dysfunction in Alzheimer's disease
Dai, L., & Shen, Y. (2021) · Aging Cell · doi:10.1111/acel.13511 · Cited by 123
The Blood–Brain Barrier, Oxidative Stress, and Insulin Resistance
Banks, W. A., & Rhea, E. M. (2021) · Antioxidants · doi:10.3390/antiox10111695 · Cited by 120
Inflammatory events at blood–brain barrier in neuroinflammatory and neurodegenerative disorders: Implications for clinical disease
de Vries, H. E., Kooij, G., Frenkel, D., Georgopoulos, S., Monsonego, A., & Janigro, D. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03702.x · Cited by 116
Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders
Xiao, M., Xiao, Z. J., Yang, B., Lan, Z., & Fang, F. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00764 · Cited by 119
The role of neutrophil granule proteins in neuroinflammation and Alzheimer’s disease
Stock, A. J., Kasus‐Jacobi, A., & Pereira, H. A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1284-4 · Cited by 117
Cytokine-mediated dysregulation of zonula occludens-1 properties in human brain microvascular endothelium
Rochfort, K. D., & Cummins, P. M. (2015) · Microvascular Research · doi:10.1016/j.mvr.2015.04.010 · Cited by 109
BACE1: More than just a β‐secretase
Taylor, H. A., Przemylska, L., Clavane, E. M., & Meakin, P. J. (2022) · Obesity Reviews · doi:10.1111/obr.13430 · Cited by 107
Oxidative stress, redox signalling and endothelial dysfunction in ageing‐related neurodegenerative diseases: a role of NADPH oxidase 2
Cahill‐Smith, S., & Li, J. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12357 · Cited by 109
Matrix Metalloproteinase in Blood-Brain Barrier Breakdown in Dementia
Weekman, E. M., & Wilcock, D. M. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150759 · Cited by 106
The role of the low-density lipoprotein receptor–related protein 1 (LRP-1) in regulating blood-brain barrier integrity
Zhao, Y., Li, Y., Zhao, J., Song, J., & Zhao, Y. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0069 · Cited by 109
Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?
Silva, T. M. D., & Miller, A. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00061 · Cited by 105
High-Density Lipoproteins and Cerebrovascular Integrity in Alzheimer’s Disease
Stukas, S. K., Robert, J., & Wellington, C. L. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.003 · Cited by 101
The Blood–Brain Barrier and Its Intercellular Junctions in Age-Related Brain Disorders
Costea, L., Mészáros, Á., Bauer, H., Bauer, H., Traweger, A., Wilhelm, I., Farkas, A. E., & Krizbai, I. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215472 · Cited by 102
Amyloid Fibrils Trigger the Release of Neutrophil Extracellular Traps (NETs), Causing Fibril Fragmentation by NET-associated Elastase
Azevedo, E. P., Guimarães-Costa, A. B., Torezani, G. S., Braga, C. A. C. A., Palhano, F. L., Kelly, J. W., Saraiva, E. M., & Foguel, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.369942 · Cited by 100
The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier
Magaki, S., Tang, Z., Tung, S., Williams, C. K., Lo, D., Yong, W. H., Khanlou, N., & Vinters, H. V. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.004 · Cited by 93
Understanding the Pathophysiology of Cerebral Amyloid Angiopathy
Gatti, L., Tinelli, F., Scelzo, E., Arioli, F., Fede, G. D., Obici, L. P., Pantoni, L., Giaccone, G., Caroppo, P., Parati, E. A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103435 · Cited by 99
Matrix metalloproteinases in Alzheimer’s disease and concurrent cerebral microbleeds.
Duits, F. H., Hernandez-Guillamon, M., Montaner, J., Goos, J. D. C., Montañola, A., Wattjes, M. P., Barkhof, F., Scheltens, P., Teunissen, C. E., & van der Flier, W. M. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-143186 · Cited by 92
From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum
Ouellette, J., & Lacoste, B. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.749026 · Cited by 91
Inhibiting Ca2+ channels in Alzheimer’s disease model mice relaxes pericytes, improves cerebral blood flow and reduces immune cell stalling and hypoxia
Korte, N., Barkaway, A., Wells, J. A., Freitas, F., Sethi, H., Andrews, S. P., Skidmore, J., Stevens, B., & Attwell, D. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01753-w · Cited by 100
Neural stem cell therapy for neurovascular injury in Alzheimer's disease
Boese, A. C., Hamblin, M. H., & Lee, J. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113112 · Cited by 89
Sphingolipids in Alzheimer's disease, how can we target them?
Crivelli, S. M., Giovagnoni, C., Visseren, L., Scheithauer, A.-L., de Wit, N. M., den Hoedt, S., Losen, M. H., Mulder, M. T., Walter, J., de Vries, H. E., et al. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.12.003 · Cited by 88
Cerebrovascular disorders: molecular insights and therapeutic opportunities
Storkebaum, E., Quaegebeur, A., Vikkula, M., & Carmeliet, P. (2011) · Nature Neuroscience · doi:10.1038/nn.2947 · Cited by 88
Interactions between glial cells and the blood-brain barrier and their role in Alzheimer's disease
Zhao, M., Jiang, X., Zhang, H., Sun, J., Pei, H., Ma, L., Cao, Y., & Li, H. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101483 · Cited by 86
Limitations of the hCMEC/D3 cell line as a model for Aβ clearance by the human blood‐brain barrier
Biemans, E. A. L. M., Jäkel, L., de Waal, R. M. W., Kuiperij, H. B., & Verbeek, M. M. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23964 · Cited by 86
Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro
Harvey, B. S., Ohlsson, K. S., Mååg, J. L. V., Musgrave, I. F., & Smid, S. D. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2011.12.015 · Cited by 82
The blood–brain and gut–vascular barriers: from the perspective of claudins
Scalise, A. A., Kakogiannos, N., Zanardi, F., Iannelli, F., & Giannotta, M. (2021) · Tissue Barriers · doi:10.1080/21688370.2021.1926190 · Cited by 86
Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream Effects
Loeffler, D. A. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230025 · Cited by 90
The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease
Wan, W., Chen, H., & Li, Y. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.825258 · Cited by 83
The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets
Qi, X.-M., & Ma, J. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0091-7 · Cited by 86
Microvascular NADPH oxidase in health and disease
Li, Y., & Pagano, P. J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.02.049 · Cited by 79
The Blood–Brain Barrier: Composition, Properties, and Roles in Brain HealthPreprint
Lacoste, B., Prat, A., Andrade, M. F., & Gu, C. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041422 · Cited by 83
NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology
Schiavone, S., Jaquet, V., Sorce, S., Dubois‐Dauphin, M., Hultqvist, M. H., Bäckdahl, L., Holmdahl, R., Colaianna, M., Cuomo, V., Trabace, L., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.36 · Cited by 75
Impairment of mitochondrial function by particulate matter: Implications for the brain
Chew, S., Kołosowska, N., Saveleva, L., Malm, T., & Kanninen, K. M. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104694 · Cited by 77
Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors
Lecordier, S., Manrique‐Castano, D., Moghrabi, Y. E., & ElAli, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.727590 · Cited by 78
Vessel-Associated Immune Cells in Cerebrovascular Diseases: From Perivascular Macrophages to Vessel-Associated Microglia
Koizumi, T., Kerkhofs, D., Mizuno, T., Steinbusch, H. W. M., & Foulquier, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01291 · Cited by 74
Establishing Co-Culture Blood–Brain Barrier Models for Different Neurodegeneration Conditions to Understand Its Effect on BBB Integrity
Park, J. S., Choe, K., Khan, A., Jo, M. H., Park, H. Y., Kang, M. H., Park, T. J., & Kim, M. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065283 · Cited by 74
P‐glycoprotein (ABCB1) and Oxidative Stress: Focus on Alzheimer’s Disease
Sita, G., Hrelia, P., Tarozzi, A., & Morroni, F. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7905486 · Cited by 73
Water-exchange MRI detects subtle blood-brain barrier breakdown in Alzheimer's disease rats
Dickie, B., Vandesquille, M., Ulloa, J. L., Boutin, H., Parkes, L. M., & Parker, G. J. M. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.09.030 · Cited by 71
Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease
Shi, H., Koronyo, Y., Fuchs, D.-T. S., Sheyn, J., Wawrowsky, K., Lahiri, S., Black, K. L., & Koronyo‐Hamaoui, M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01076-4 · Cited by 71
Quercetin protects human brain microvascular endothelial cells from fibrillar β-amyloid1–40-induced toxicity
Li, Y., Zhou, S., Li, J., Sun, Y., Hamlati, H., Liu, R., & Zhang, T. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2014.12.003 · Cited by 71
Hyperglycemia Increases the Production of Amyloid Beta‐Peptide Leading to Decreased Endothelial Tight Junction
Chao, A., Lee, T.-Y., Juo, S. H., & Yang, D. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12503 · Cited by 69
Addressing Blood–Brain Barrier Impairment in Alzheimer’s Disease
Sharma, C., Woo, H., & Kim, S. R. (2022) · Biomedicines · doi:10.3390/biomedicines10040742 · Cited by 71
ZO Proteins and Redox-Dependent Processes
González‐Mariscal, L., Quirós, M., & Díaz-Coránguez, M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3913 · Cited by 66
B Cells in Neuroinflammation: New Perspectives and Mechanistic Insights
Ahn, J. J., Abu-Rub, M., & Miller, R. H. (2021) · Cells · doi:10.3390/cells10071605 · Cited by 66
Mechanobiology of the blood-brain barrier during development, disease and ageing
Konig, S., Jayarajan, V., Wray, S., Kamm, R. D., & Moeendarbary, E. (2025) · Nature Communications · doi:10.1038/s41467-025-61888-7 · Cited by 72
High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity
Qosa, H., Mohamed, L. A., Rihani, S. B. A., Batarseh, Y. S., Duong, Q.-V., Keller, J. N., & Kaddoumi, A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151179 · Cited by 64

Authors: Carrano, A., Hoozemans, J. J. M., van der Vies, S. M., Rozemuller, A. J. M., van Horssen, J., & de Vries, H. E.
Affiliations: Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Departments of Molecular Cell Biology and Immunology (MCBI) and Pathology, VU University Medical Center, Amsterdam, The Netherlands.
ORCID: Carrano, Anna
Hoozemans, Jeroen J.M.
Venue: Antioxidants & Redox Signaling
Publisher: SAGE Publications
Published: 2011-09
Volume: 15
Issue: 5
Pages: 1167-1178
ISSN: 1523-0864 (ISSN-L)
1557-7716
DOI: 10.1089/ars.2011.3895
OpenAlex: W2054446458
Cited by: 293
References: 50
Citations by year: 2026: 11 · 2025: 16 · 2024: 30 · 2023: 21 · 2022: 34 · 2021: 27 · 2020: 21 · 2019: 13 · 2018: 17 · 2017: 11 · 2016: 18 · 2015: 20 · 2014: 14 · 2013: 16 · 2012: 10
FWCI: 9.19
Type: journal article
Language: en
Open access: closed
Locations: Antioxidants and Redox Signaling (publishedVersion)
PubMed (publishedVersion)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
VU Research Portal (publishedVersion)
Pure Amsterdam UMC (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Funders: Chinese Academy of Agricultural Sciences
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
Keywords: cerebral amyloid angiopathy, amyloid-beta, blood-brain barrier, tight junctions, oxidative stress, reactive oxygen species, NADPH oxidase 2, microglia, receptor for advanced glycation end products, RAGE, brain endothelial cells, occludin, claudin-5, ZO-1, Alzheimer's disease, antioxidant defense
MeSH terms: Receptor for Advanced Glycation End Products, NADPH Oxidase 2, Aged, Aged, 80 and over, Antioxidants, Blood-Brain Barrier, Capillaries, Cell Line, Female, Gene Expression Regulation, Humans, Male, Membrane Glycoproteins, Membrane Proteins, Phosphoproteins, RNA, Messenger, Down-Regulation, Amyloid beta-Peptides, Cerebral Amyloid Angiopathy, Reactive Oxygen Species, Microglia, Oxidative Stress, Tight Junctions, NADPH Oxidases, Endothelial Cells, Occludin, Zonula Occludens-1 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks